Clinical Trial Update: CMAB008 With MTX Therapy in Adult Patients With Moderately to Severely Active Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial update for CMAB008 in combination with methotrexate in adults with moderately to severely active rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CMAB008
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Shanghai Biomabs Pharmaceutical Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED